{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T12:26:26Z","timestamp":1781871986201,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00417-024-06685-6","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T15:55:22Z","timestamp":1731599722000},"page":"1115-1123","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Epidemiology, trends, and survival of ocular and orbital rhabdomyosarcoma: a nationwide study in the USA (1996\u20132018)"],"prefix":"10.1007","volume":"263","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2209-8187","authenticated-orcid":false,"given":"Ahmad","family":"Kunbaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0930-4583","authenticated-orcid":false,"given":"Ahmad Samir","family":"Alfaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"6685_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/J.CCR.2011.01.044","volume":"19","author":"VD Soleimani","year":"2011","unstructured":"Soleimani VD, Rudnicki MA (2011) New insights into the origin and the genetic basis of rhabdomyosarcomas. Cancer Cell 19:157. https:\/\/doi.org\/10.1016\/J.CCR.2011.01.044","journal-title":"Cancer Cell"},{"key":"6685_CR2","doi-asserted-by":"publisher","unstructured":"Frederick P, Li JFF (1969) Rhabdomyosarcoma in children: epidemiologic study and identification of a familial caneer syndrome. JNCI: J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/43.6.1365","DOI":"10.1093\/jnci\/43.6.1365"},{"key":"6685_CR3","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/JNCI\/DJAA204","volume":"113","author":"H Li","year":"2021","unstructured":"Li H, Sisoudiya SD, Martin-Giacalone BA et al (2021) Germline cancer predisposition variants in pediatric rhabdomyosarcoma: a report from the children\u2019s oncology group. J Natl Cancer Inst 113:875\u2013883. https:\/\/doi.org\/10.1093\/JNCI\/DJAA204","journal-title":"J Natl Cancer Inst"},{"key":"6685_CR4","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.5858\/ARPA.2014-0475-OA","volume":"139","author":"ER Rudzinski","year":"2015","unstructured":"Rudzinski ER, Anderson JR, Hawkins DS et al (2015) The world health organization classification of skeletal muscle tumors in pediatric rhabdomyosarcoma: a report from the children\u2019s oncology group. Arch Pathol Lab Med 139:1281\u20131287. https:\/\/doi.org\/10.5858\/ARPA.2014-0475-OA","journal-title":"Arch Pathol Lab Med"},{"key":"6685_CR5","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1093\/JNCI\/91.12.1051","volume":"91","author":"MS Linet","year":"1999","unstructured":"Linet MS, Ries LAG, Smith MA et al (1999) Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst 91:1051\u20131058. https:\/\/doi.org\/10.1093\/JNCI\/91.12.1051","journal-title":"J Natl Cancer Inst"},{"key":"6685_CR6","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1200\/JCO.1995.13.3.610","volume":"13","author":"W Crist","year":"1995","unstructured":"Crist W, Gehan EA, Ragab AH et al (1995) The third intergroup rhabdomyosarcoma study. J Clin Oncol 13:610\u2013630. https:\/\/doi.org\/10.1200\/JCO.1995.13.3.610","journal-title":"J Clin Oncol"},{"key":"6685_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/J.SJOPT.2013.06.004","volume":"27","author":"L Jurdy","year":"2013","unstructured":"Jurdy L, Merks JHM, Pieters BR et al (2013) Orbital rhabdomyosarcomas: a review. Saudi J Ophthalmol 27:167\u2013175. https:\/\/doi.org\/10.1016\/J.SJOPT.2013.06.004","journal-title":"Saudi J Ophthalmol"},{"key":"6685_CR8","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1200\/JCO.2008.19.7483","volume":"27","author":"I Sultan","year":"2009","unstructured":"Sultan I, Qaddoumi I, Yaser S et al (2009) Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. J Clin Oncol 27:3391\u20133397. https:\/\/doi.org\/10.1200\/JCO.2008.19.7483","journal-title":"J Clin Oncol"},{"key":"6685_CR9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/J.CANEP.2014.07.001","volume":"38","author":"WM Hassan","year":"2014","unstructured":"Hassan WM, Alfaar AS, Bakry MS, Ezzat S (2014) Orbital tumors in USA: difference in survival patterns. Cancer Epidemiol 38:515\u2013522. https:\/\/doi.org\/10.1016\/J.CANEP.2014.07.001","journal-title":"Cancer Epidemiol"},{"key":"6685_CR10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1470-2045(18)30909-4","volume":"20","author":"ZJ Ward","year":"2019","unstructured":"Ward ZJ, Yeh JM, Bhakta N et al (2019) Estimating the total incidence of global childhood cancer: a simulation-based analysis. Lancet Oncol 20:483\u2013493. https:\/\/doi.org\/10.1016\/S1470-2045(18)30909-4","journal-title":"Lancet Oncol"},{"key":"6685_CR11","first-page":"69","volume":"56","author":"RB Raney Jr","year":"1981","unstructured":"Raney Jr RB (1981) Special considerations related to primary site in rhabdomyosarcoma: experience of the intergroup rhabdomyosarcoma study, 1972\u201376 - PubMed. Natl Cancer Inst Monogr 56:69\u201374","journal-title":"Natl Cancer Inst Monogr"},{"key":"6685_CR12","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1002\/cncr.34723","volume":"129","author":"J Metts","year":"2023","unstructured":"Metts J, Xue W, Gao Z et al (2023) Survival of patients with orbital and eyelid rhabdomyosarcoma treated on children\u2019s oncology group studies from 1997 to 2013: a report from the children\u2019s oncology Group. Cancer 129:1735\u20131743. https:\/\/doi.org\/10.1002\/cncr.34723","journal-title":"Cancer"},{"key":"6685_CR13","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.2147\/CMAR.S163932","volume":"10","author":"LY Tang","year":"2018","unstructured":"Tang LY, Zhang MX, Lu DH et al (2018) The prognosis and effects of local treatment strategies for orbital embryonal rhabdomyosarcoma: a population-based study. Cancer Manag Res 10:1727\u20131734. https:\/\/doi.org\/10.2147\/CMAR.S163932","journal-title":"Cancer Manag Res"},{"key":"6685_CR14","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1541-0420.2006.00528.x","volume":"62","author":"MP Fay","year":"2006","unstructured":"Fay MP, Tiwari RC, Feuer EJ, Zou Z (2006) Estimating average annual percent change for disease rates without assuming constant change. Biometrics 62:847\u2013854. https:\/\/doi.org\/10.1111\/j.1541-0420.2006.00528.x","journal-title":"Biometrics"},{"key":"6685_CR15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335\u2013351. https:\/\/doi.org\/10.1002\/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z","journal-title":"Stat Med"},{"key":"6685_CR16","unstructured":"Cho H, Howlader N, Mariotto AB, Cronin KA (2011) Estimating relative survival for cancer patients from the SEER Program using expected rates based on Ederer I versus Ederer II method. Washington DC. https:\/\/surveillance.cancer.gov\/reports\/tech2011.01.pdf"},{"key":"6685_CR17","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2307\/2531329","volume":"39","author":"CC Brown","year":"1983","unstructured":"Brown CC (1983) The statistical comparison of relative survival rates. Biometrics 39:941. https:\/\/doi.org\/10.2307\/2531329","journal-title":"Biometrics"},{"key":"6685_CR18","unstructured":"Bethesda M (2022) NCI. Surveillance research program, National Cancer Institute SEER*Stat software version 8.4.0.1 [Internet]. In: National Cancer Institute. https:\/\/seer.cancer.gov\/seerstat. Accessed 7 May 2023"},{"key":"6685_CR19","doi-asserted-by":"publisher","unstructured":"Kim H-J, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates - PubMed. Stat Med 19:335\u2013351. https:\/\/doi.org\/10.1002\/(sici)1097-0258(20000215)19:3%3c335::aid-sim336%3e3.0.co;2-z","DOI":"10.1002\/(sici)1097-0258(20000215)19:3%3c335::aid-sim336%3e3.0.co;2-z"},{"key":"6685_CR20","unstructured":"Statistical Research and Applications, Branch NCI (2022) Joinpoint regression program. https:\/\/surveillance.cancer.gov\/joinpoint\/. Accessed 7 May 2023"},{"key":"6685_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/J.1467-985X.2009.00580.X","volume":"172","author":"B Yu","year":"2009","unstructured":"Yu B, Huang L, Tiwari RC et al (2009) Modelling population-based cancer survival trends using join point models for grouped survival data. J R Stat Soc Ser Stat Soc 172:405. https:\/\/doi.org\/10.1111\/J.1467-985X.2009.00580.X","journal-title":"J R Stat Soc Ser Stat Soc"},{"key":"6685_CR22","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1177\/0194599811417063","volume":"145","author":"JH Turner","year":"2011","unstructured":"Turner JH, Richmon JD (2011) Head and neck rhabdomyosarcoma: a critical analysis of population-based incidence and survival data. Otolaryngol Head Neck Surg 145:967\u2013973. https:\/\/doi.org\/10.1177\/0194599811417063","journal-title":"Otolaryngol Head Neck Surg"},{"key":"6685_CR23","doi-asserted-by":"publisher","unstructured":"Wyatt KD, Birz S, Hawkins DS et al (2022) Creating a data commons: the INternational soft tissue SaRcoma ConsorTium (INSTRuCT). Pediatr Blood Cancer 69. https:\/\/doi.org\/10.1002\/pbc.29924","DOI":"10.1002\/pbc.29924"},{"key":"6685_CR24","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.ejca.2008.11.032","volume":"45","author":"F Bray","year":"2009","unstructured":"Bray F, Parkin DM (2009) Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer 45:747\u2013755. https:\/\/doi.org\/10.1016\/j.ejca.2008.11.032","journal-title":"Eur J Cancer"},{"key":"6685_CR25","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"6685_CR26","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1055\/s-0043-1768179","volume":"45","author":"V Singh","year":"2024","unstructured":"Singh V, Saini V, Ora M, Gambhir S (2024) Paranasal sinus embryonal rhabdomyosarcoma metastasizing to breast and ovary on PET\/CT\u2014a case report with the review of literature. Indian J Med Pediatr Oncol 45:454\u2013458. https:\/\/doi.org\/10.1055\/s-0043-1768179","journal-title":"Indian J Med Pediatr Oncol"},{"key":"6685_CR27","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.3390\/jcm10092028","volume":"10","author":"BA Martin-Giacalone","year":"2021","unstructured":"Martin-Giacalone BA, Weinstein PA, Plon SE, Lupo PJ (2021) Pediatric rhabdomyosarcoma: epidemiology and genetic susceptibility. J Clin Med 10:2028. https:\/\/doi.org\/10.3390\/jcm10092028","journal-title":"J Clin Med"},{"key":"6685_CR28","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1002\/cncr.24465","volume":"115","author":"S Ognjanovic","year":"2009","unstructured":"Ognjanovic S, Linabery AM, Charbonneau B, Ross JA (2009) Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975\u20132005. Cancer 115:4218\u20134226. https:\/\/doi.org\/10.1002\/cncr.24465","journal-title":"Cancer"},{"key":"6685_CR29","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1007\/s00247-023-05596-8","volume":"53","author":"ISA de Vries","year":"2023","unstructured":"de Vries ISA, van Ewijk R, Adriaansen LME et al (2023) Imaging in rhabdomyosarcoma: a patient journey. Pediatr Radiol 53:788\u2013812. https:\/\/doi.org\/10.1007\/s00247-023-05596-8","journal-title":"Pediatr Radiol"},{"key":"6685_CR30","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/S00247-010-1787-3","volume":"40","author":"NJM Freling","year":"2010","unstructured":"Freling NJM, Merks JHM, Saeed P et al (2010) Imaging findings in craniofacial childhood rhabdomyosarcoma. Pediatr Radiol 40:1723\u20131738. https:\/\/doi.org\/10.1007\/S00247-010-1787-3","journal-title":"Pediatr Radiol"},{"key":"6685_CR31","doi-asserted-by":"publisher","unstructured":"Zhen H, Liu Z, Guan H et al (2021) Second malignant neoplasms in patients with rhabdomyosarcoma.\u00a0Front Oncol 11.\u00a0https:\/\/doi.org\/10.3389\/FONC.2021.757095.\u00a0","DOI":"10.3389\/FONC.2021.757095"},{"key":"6685_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1200\/JCO.2001.19.1.197","volume":"19","author":"O Oberlin","year":"2001","unstructured":"Oberlin O, Rey A, Anderson J et al (2001) Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment\u2013results of an international workshop. J Clin Oncol 19:197\u2013204. https:\/\/doi.org\/10.1200\/JCO.2001.19.1.197","journal-title":"J Clin Oncol"},{"key":"6685_CR33","doi-asserted-by":"publisher","unstructured":"Chen C, Dorado Garcia H, Scheer M, Henssen AG (2019) Current and future treatment strategies for rhabdomyosarcoma. Front Oncol 9. https:\/\/doi.org\/10.3389\/fonc.2019.01458","DOI":"10.3389\/fonc.2019.01458"},{"key":"6685_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/9010496","volume":"2020","author":"A Proudfit","year":"2020","unstructured":"Proudfit A, Bhunia N, Pore D et al (2020) Pharmacologic inhibition of Ezrin-Radixin-Moesin phosphorylation is a novel therapeutic strategy in rhabdomyosarcoma. Sarcoma 2020:1\u201311. https:\/\/doi.org\/10.1155\/2020\/9010496","journal-title":"Sarcoma"},{"key":"6685_CR35","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1200\/JCO.20.03060","volume":"39","author":"JF Shern","year":"2021","unstructured":"Shern JF, Selfe J, Izquierdo E et al (2021) Genomic classification and clinical outcome in rhabdomyosarcoma: a report from an international consortium. J Clin Oncol 39:2859\u20132871. https:\/\/doi.org\/10.1200\/JCO.20.03060","journal-title":"J Clin Oncol"},{"key":"6685_CR36","doi-asserted-by":"publisher","unstructured":"Hiniker SM, Donaldson SS (2015) Recent advances in understanding and managing rhabdomyosarcoma.\u00a0F1000Prime Rep 7.\u00a0https:\/\/doi.org\/10.12703\/P7-59.\u00a0","DOI":"10.12703\/P7-59"},{"key":"6685_CR37","first-page":"249","volume":"24","author":"S Staibano","year":"2004","unstructured":"Staibano S, Franco R, Tranfa F et al (2004) Orbital rhabdomyosarcoma: relationship between DNA ploidy, p53, bcl-2, MDR-1 and Ki67 (MIB1) expression and clinical behavior. Anticancer Res 24:249\u2013257","journal-title":"Anticancer Res"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06685-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-024-06685-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06685-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T15:03:20Z","timestamp":1747839800000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-024-06685-6"}},"subtitle":["Ocular and orbital rhabdomyosarcoma in the USA"],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["6685"],"URL":"https:\/\/doi.org\/10.1007\/s00417-024-06685-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"22 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to ethical principles including the Declaration of Helsinki and\u00a0good clinical practice guidelines. The analysis was conducted using anonymized\u00a0patient data made available by the North American Association of Central Cancer\u00a0Registries (NAACCR); therefore, the study did not require IRB approval or consent\u00a0forms.\u00a0","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement\u00a0"}},{"value":"All authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}